Congratulations to Dr. Eileen Kennedy, Dr. Samuel C. Benedict Professor and Interim Assistant Head, Department of Pharmaceutical and Biomedical Sciences, who has just received a U.S. patent for “Disruption of the WAVE3 protein complex for suppression of invasion and metastasis.” Dr. Kennedy worked with her colleague, Dr. John Cowell, associate cancer center director for basic research at Augusta University, on the patent, which can be viewed here.

Eileen Kennedy Receives U.S. Patent
- Billie Wickliffe ’49, ’59, ’63, ’67
- College of Pharmacy 60 at 60
- Department Head of Clinical and Administrative Pharmacy Search
- Faculty and Staff Wellness Resources
- Home
- PharmCast
- Strategic Plan 2025: Our Prescription for the Future
- Student Wellness Resources
- Virtual Homecoming 2020
- Virtual Pharmtoberfest 2020
- About
- Academic Programs
- Bachelor of Science
- Master of Science
- Master of Science in Clinical & Experimental Therapeutics (MCET)
- Master of Science in Pharmaceutical Health Services, Outcomes, & Policy
- Pharmaceutical & Biomedical Sciences
- Regulatory Sciences Master’s Degree
- Toxicology (Clinical & Administrative Pharmacy)
- Toxicology (Pharmaceutical & Biomedical Sciences)
- Ph.D.
- Professional Degree (Pharm.D.)
- Certificates
- Dual Degree
- Experience Programs
- Interprofessional Education
- Residency Programs
- Departments
- Academic
- Clinical & Administrative Pharmacy
- Pharmaceutical & Biomedical Sciences
- Administrative Offices
- Academic
- Directory
- Research
- News & Events
- Students
- Alumni & Giving
- Faculty & Staff
- Giving
- Apply Now